Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
FDA appears less prickly toward Moderna mRNA flu shot
Briefing documents released by the FDA Tuesday appear to bode well for Moderna's chances ahead of an upcoming advisory committee grilling.
Fraiser Kansteiner
Jun 16, 2026 2:46pm
Edgewise data power rival to BMS and Cytokinetics toward phase 3
Jun 16, 2026 10:39am
Novartis dystrophy data tee up regulatory talks on Avidity drug
Jun 12, 2026 4:30am
Sanofi halts phase 3 autoimmune trial early over lackluster data
Jun 10, 2026 4:25am
Bial bails after Parkinson’s fail, axing asset over phase 2 miss
Jun 9, 2026 5:22am
ADA: Lilly offers deeper glimpse into triple-G obesity candidate
Jun 6, 2026 3:28pm
